Original language | English (US) |
---|---|
Pages (from-to) | 821-822 |
Number of pages | 2 |
Journal | JAMA Psychiatry |
Volume | 78 |
Issue number | 8 |
DOIs |
|
State | Published - Aug 2021 |
Funding
received grants from the National Institutes of Health, Substance Abuse and Mental Health Services Administration, and Boehringer Ingelheim; personal fees from Boehringer Ingelheim, New England Research Institute, and Takeda; and has a patent issued for a method of treating prodromal schizophrenia with glycine agonists. No other disclosures were reported.
ASJC Scopus subject areas
- Psychiatry and Mental health